Table 2.
Relationship between YTHDF2 and clinicopathological factors of LUSC patients
Clinicopathological parameters | N | YTHDF2 Low (n = 29) |
YTHDF2 High (n = 44) |
P |
---|---|---|---|---|
Gender | 0.298 | |||
Male | 66 | 28 | 38 | |
Female | 7 | 1 | 6 | |
Age | 0.337 | |||
< 60 | 23 | 11 | 12 | |
≥ 60 | 50 | 18 | 32 | |
Differentiation | 0.550 | |||
Good | 3 | 0 | 3 | |
Moderate | 53 | 22 | 31 | |
Poor | 17 | 7 | 10 | |
pT classification | 0.901 | |||
pT1 | 12 | 4 | 8 | |
pT2 | 32 | 13 | 19 | |
pT3 | 29 | 12 | 17 | |
pN | 0.002 | |||
− | 27 | 17 | 10 | 0.007 |
+ | 46 | 12 | 34 | |
pTNM stage | ||||
pI | 12 | 6 | 6 | |
pII | 30 | 17 | 13 | |
pIIIa | 31 | 6 | 25 |
P-value: chi-squared test, Fisher’s exact probability test. pT classification, tumor size; pN, lymph node metastasis and pTNM stage, tumor stage